ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

BACKGROUND: Drug resistance is one of the major concerns in the treatment of hepatocellular carcinoma (HCC). The aim of the present study was to determine whether aberrant high expression of the inhibitor of differentiation 1(ID1) confers oxaliplatin-resistance to HCC by activating the pentose phosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Yin, Xin, Tang, Bei, Li, Jing-Huan, Wang, Yan, Zhang, Lan, Xie, Xiao-Ying, Zhang, Bo-Heng, Qiu, Shuang-Jian, Wu, Wei-Zhong, Ren, Zheng-Gang
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701377/
https://ncbi.nlm.nih.gov/pubmed/29169374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0637-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars